Neurotransmission Across the Synaptic Cleft: Mechanism and Modulation

Yes. Chemical synaptic transmission involves neurotransmitter release into and diffusion across the synaptic cleft (20–40 nm).

Step-by-Step

  1. Action potential arrives at presynaptic terminal.
  2. Voltage-gated Ca²⁺ channels open → Ca²⁺ influx.
  3. Ca²⁺ triggers SNARE-mediated vesicle fusion with active zone membrane.
  4. Exocytosis releases neurotransmitter (NT) into cleft.
  5. NT diffuses across cleft (random Brownian motion; <1 ms).
  6. NT binds postsynaptic receptors (ionotropic = ligand-gated ion channels; metabotropic = G-protein-coupled).
  7. Ionotropic: Rapid (sub-ms) ion flux → EPSP (excitatory, e.g., AMPA glutamate → Na⁺ influx) or IPSP (inhibitory, e.g., GABAA → Cl⁻ influx).
  8. Metabotropic: Slow (ms–s), modulatory (cAMP, IP₃/DAG, ion channel modulation).
  9. Termination: Reuptake (transporters: SERT, DAT, NET, GAT), enzymatic degradation (AChE for acetylcholine), diffusion.

Key Concepts

  • Quantal release: Vesicles release fixed packets; summation determines postsynaptic response.
  • Plasticity: LTP/LTD modify receptor number/sensitivity, vesicle probability.
  • Neuromodulators: Dopamine, serotonin, norepinephrine, acetylcholine (metabotropic) alter circuit gain.

Pharmacological Targets

Most psychoactive drugs act at synapses: SSRIs (reuptake), benzodiazepines (GABAA PAM), antipsychotics (D₂ antagonism), botulinum toxin (blocks vesicle fusion).

The synaptic cleft is the critical computational space of the nervous system.

Brain & Nervous System - Related Articles